ReP USP - Resultado da busca

Artigo de periodico
Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments (2022)
Bayer, Hugo; Stern, Cristina A. J.; Troyner, Fernanda; Gazarini, Lucas; Guimarães, Francisco Silveira ; Bertoglio, Leandro J.
Source: Neuropharmacology. Unidade: FMRP
Subjects: COMPORTAMENTO, CANABINOIDES, TRANSTORNOS DA MEMÓRIA, FARMACOTERAPIA, PLASTICIDADE NEURONAL, CÓRTEX PRÉ-FRONTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAYER, Hugo et al. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments. Neuropharmacology, v. 205, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108913. Acesso em: 02 nov. 2024.
APA
Bayer, H., Stern, C. A. J., Troyner, F., Gazarini, L., Guimarães, F. S., & Bertoglio, L. J. (2022). Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments. Neuropharmacology, 205, 1-11. doi:10.1016/j.neuropharm.2021.108913
NLM
Bayer H, Stern CAJ, Troyner F, Gazarini L, Guimarães FS, Bertoglio LJ. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments [Internet]. Neuropharmacology. 2022 ; 205 1-11.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108913
Vancouver
Bayer H, Stern CAJ, Troyner F, Gazarini L, Guimarães FS, Bertoglio LJ. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments [Internet]. Neuropharmacology. 2022 ; 205 1-11.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108913
Artigo de periodico
Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects (2021)
Sartim, Ariandra Guerini; Marques, J.; Silveira, Kennia Moura; Nunes, Pedro Henrique Gobira; Guimarães, Francisco Silveira ; Wegener, G.; Wegener, Sâmia Regiane Lourenço Joca
Source: Neuropharmacology. Unidades: FMRP, FCFRP
Subjects: ANTIDEPRESSIVOS, COMPORTAMENTO ANIMAL, CANABINOIDES, DEPRESSÃO, HIPOCAMPO, ATIVIDADE MOTORA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARTIM, Ariandra Guerini et al. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, v. 195, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108679. Acesso em: 02 nov. 2024.
APA
Sartim, A. G., Marques, J., Silveira, K. M., Nunes, P. H. G., Guimarães, F. S., Wegener, G., & Wegener, S. R. L. J. (2021). Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, 195. doi:10.1016/j.neuropharm.2021.108679
NLM
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679
Vancouver
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679
Artigo de periodico
Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats (2021)
Estela, Airam Nicole Vivanco; Pereira, Maurício dos Santos; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida ; Nascimento, Glauce Crivelaro do
Source: Neuropharmacology. Unidades: FORP, FMRP
Subjects: CANABINOIDES, ANALGÉSICOS, ANTICONVULSIVANTES, DOR FACIAL, NOCICEPTIVIDADE, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESTELA, Airam Nicole Vivanco et al. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats. Neuropharmacology, v. 196, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108700. Acesso em: 02 nov. 2024.
APA
Estela, A. N. V., Pereira, M. dos S., Guimarães, F. S., Del Bel, E. A., & Nascimento, G. C. do. (2021). Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats. Neuropharmacology, 196. doi:10.1016/j.neuropharm.2021.108700
NLM
Estela ANV, Pereira M dos S, Guimarães FS, Del Bel EA, Nascimento GC do. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108700
Vancouver
Estela ANV, Pereira M dos S, Guimarães FS, Del Bel EA, Nascimento GC do. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108700
Artigo de periodico
Hemopressin as a breakthrough for the cannabinoid field (2021)
Heimann, Andrea S. ; Dale, Camila Squarzoni ; Guimarães, Francisco Silveira ; Reis, Ricardo A. M. ; Navon, Ami ; Shmuelov, Michal A.; Rioli, Vanessa; Gomes, Ivone; Devi, Lakshmi L.; Ferro, Emer Suavinho
Source: Neuropharmacology. Unidades: ICB, FMRP
Subjects: ANATOMIA, FARMACOLOGIA, CANABINOIDES, RECEPTORES, PEPTÍDEOS, HEMOGLOBINAS, CAMUNDONGOS, MITOCÔNDRIAS, ANTI-INFLAMATÓRIOS, MATERIAIS NANOESTRUTURADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HEIMANN, Andrea S. et al. Hemopressin as a breakthrough for the cannabinoid field. Neuropharmacology, v. 183, p. 12 , 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2020.108406. Acesso em: 02 nov. 2024.
APA
Heimann, A. S., Dale, C. S., Guimarães, F. S., Reis, R. A. M., Navon, A., Shmuelov, M. A., et al. (2021). Hemopressin as a breakthrough for the cannabinoid field. Neuropharmacology, 183, 12 . doi:10.1016/j.neuropharm.2020.108406
NLM
Heimann AS, Dale CS, Guimarães FS, Reis RAM, Navon A, Shmuelov MA, Rioli V, Gomes I, Devi LL, Ferro ES. Hemopressin as a breakthrough for the cannabinoid field [Internet]. Neuropharmacology. 2021 ; 183 12 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2020.108406
Vancouver
Heimann AS, Dale CS, Guimarães FS, Reis RAM, Navon A, Shmuelov MA, Rioli V, Gomes I, Devi LL, Ferro ES. Hemopressin as a breakthrough for the cannabinoid field [Internet]. Neuropharmacology. 2021 ; 183 12 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2020.108406
Artigo de periodico
Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? (2021)
Salviato, Beatriz Zanutto; Raymundi, Ana Maria; Silva, Thiago Rodrigues da; Salemme, Bruna Wuilleumier; Sohn, Jeferson Machado Batista; Araújo, Fabiano Soares; Guimarães, Francisco Silveira ; Bertoglio, Leandro José; Stern, Cristina Aparecida
Source: Neuropharmacology. Unidade: FMRP
Subjects: DIFERENÇAS SEXUAIS (PSICOGÊNESE), CANABINOIDES, ANSIOLÍTICOS, ANSIEDADE, NEUROTRANSMISSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALVIATO, Beatriz Zanutto et al. Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?. Neuropharmacology, v. 196, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108684. Acesso em: 02 nov. 2024.
APA
Salviato, B. Z., Raymundi, A. M., Silva, T. R. da, Salemme, B. W., Sohn, J. M. B., Araújo, F. S., et al. (2021). Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? Neuropharmacology, 196. doi:10.1016/j.neuropharm.2021.108684
NLM
Salviato BZ, Raymundi AM, Silva TR da, Salemme BW, Sohn JMB, Araújo FS, Guimarães FS, Bertoglio LJ, Stern CA. Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108684
Vancouver
Salviato BZ, Raymundi AM, Silva TR da, Salemme BW, Sohn JMB, Araújo FS, Guimarães FS, Bertoglio LJ, Stern CA. Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108684
Artigo de periodico
Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy (2021)
Perez, Matheus; Cartarozzi, Luciana Politti; Chiarotto, Gabriela Bortolança; Guimarães, Francisco Silveira ; Oliveira, Alexandre Leite Rodrigues de
Source: Neuropharmacology. Unidades: EEFERP, FMRP
Subjects: AXÔNIOS, CANABINOIDES, NEURÔNIOS MOTORES, NERVOS PERIFÉRICOS, NERVO CIÁTICO, NERVOS ESPINHAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREZ, Matheus et al. Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy. Neuropharmacology, v. 197, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108726. Acesso em: 02 nov. 2024.
APA
Perez, M., Cartarozzi, L. P., Chiarotto, G. B., Guimarães, F. S., & Oliveira, A. L. R. de. (2021). Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy. Neuropharmacology, 197. doi:10.1016/j.neuropharm.2021.108726
NLM
Perez M, Cartarozzi LP, Chiarotto GB, Guimarães FS, Oliveira ALR de. Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy [Internet]. Neuropharmacology. 2021 ; 197[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108726
Vancouver
Perez M, Cartarozzi LP, Chiarotto GB, Guimarães FS, Oliveira ALR de. Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy [Internet]. Neuropharmacology. 2021 ; 197[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108726
Artigo de periodico
Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease (2020)
Nascimento, Glauce Crivelaro do; Ferrari, Daniele Pereira; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida ; Bortolanza, Mariza; Ferreira Junior, Nilson Carlos
Source: Neuropharmacology. Unidades: FORP, FMRP
Subjects: CANABINOIDES, NOCICEPTIVIDADE, DOR, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Glauce Crivelaro do et al. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease. Neuropharmacology, v. 163, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2019.107808. Acesso em: 02 nov. 2024.
APA
Nascimento, G. C. do, Ferrari, D. P., Guimarães, F. S., Del Bel, E. A., Bortolanza, M., & Ferreira Junior, N. C. (2020). Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease. Neuropharmacology, 163. doi:10.1016/j.neuropharm.2019.107808
NLM
Nascimento GC do, Ferrari DP, Guimarães FS, Del Bel EA, Bortolanza M, Ferreira Junior NC. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease [Internet]. Neuropharmacology. 2020 ; 163[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.107808
Vancouver
Nascimento GC do, Ferrari DP, Guimarães FS, Del Bel EA, Bortolanza M, Ferreira Junior NC. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease [Internet]. Neuropharmacology. 2020 ; 163[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.107808
Artigo de periodico
Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative (2018)
Perez, Matheus; Cartarozzi, Luciana Politti; Chiarotto, Gabriela Bortolança; Oliveira, Simone Alves de; Guimarães, Francisco Silveira; Oliveira, Alexandre Leite Rodrigues de
Source: Neuropharmacology. Unidade: FMRP
Subjects: NEUROFARMACOLOGIA, APOPTOSE, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREZ, Matheus et al. Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative. Neuropharmacology, v. 140, p. 201-208, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2018.08.009. Acesso em: 02 nov. 2024.
APA
Perez, M., Cartarozzi, L. P., Chiarotto, G. B., Oliveira, S. A. de, Guimarães, F. S., & Oliveira, A. L. R. de. (2018). Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative. Neuropharmacology, 140, 201-208. doi:10.1016/j.neuropharm.2018.08.009
NLM
Perez M, Cartarozzi LP, Chiarotto GB, Oliveira SA de, Guimarães FS, Oliveira ALR de. Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative [Internet]. Neuropharmacology. 2018 ; 140 201-208.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.08.009
Vancouver
Perez M, Cartarozzi LP, Chiarotto GB, Oliveira SA de, Guimarães FS, Oliveira ALR de. Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative [Internet]. Neuropharmacology. 2018 ; 140 201-208.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.08.009
Artigo de periodico
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anixiety-like behavior in rats (2013)
Lisboa, S. F.; Magesto, A. C.; Aguiar, José Carlos de; Resstel, Leonardo Barbosa Moraes; Guimarães, Francisco Silveira
Source: Neuropharmacology. Unidade: FMRP
Subjects: ANSIEDADE, ÓXIDO NÍTRICO, GLUTAMATOS, GABA, SUBSTÂNCIA CINZENTA PERIAQUEDUTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LISBOA, S. F. et al. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anixiety-like behavior in rats. Neuropharmacology, v. 75, p. 86-94, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2013.07.008. Acesso em: 02 nov. 2024.
APA
Lisboa, S. F., Magesto, A. C., Aguiar, J. C. de, Resstel, L. B. M., & Guimarães, F. S. (2013). Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anixiety-like behavior in rats. Neuropharmacology, 75, 86-94. doi:10.1016/j.neuropharm.2013.07.008
NLM
Lisboa SF, Magesto AC, Aguiar JC de, Resstel LBM, Guimarães FS. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anixiety-like behavior in rats [Internet]. Neuropharmacology. 2013 ; 75 86-94.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2013.07.008
Vancouver
Lisboa SF, Magesto AC, Aguiar JC de, Resstel LBM, Guimarães FS. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anixiety-like behavior in rats [Internet]. Neuropharmacology. 2013 ; 75 86-94.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2013.07.008
Artigo de periodico
Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence (2012)
Montezuma, Karina; Biojone, Caroline; Lisboa, Sabrina Francesca; Cunha, Fernando de Queiroz; Guimarães, Francisco Silveira; Joca, Sâmia Regiane Lourenço
Source: Neuropharmacology. Unidades: FMRP, FCFRP
Subjects: ÓXIDO NÍTRICO, DEPRESSÃO, ESTRESSE, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEZUMA, Karina et al. Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence. Neuropharmacology, v. 62, n. 1, p. 485-491, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2011.09.004. Acesso em: 02 nov. 2024.
APA
Montezuma, K., Biojone, C., Lisboa, S. F., Cunha, F. de Q., Guimarães, F. S., & Joca, S. R. L. (2012). Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence. Neuropharmacology, 62( 1), 485-491. doi:10.1016/j.neuropharm.2011.09.004
NLM
Montezuma K, Biojone C, Lisboa SF, Cunha F de Q, Guimarães FS, Joca SRL. Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence [Internet]. Neuropharmacology. 2012 ; 62( 1): 485-491.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2011.09.004
Vancouver
Montezuma K, Biojone C, Lisboa SF, Cunha F de Q, Guimarães FS, Joca SRL. Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence [Internet]. Neuropharmacology. 2012 ; 62( 1): 485-491.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2011.09.004
Artigo de periodico
The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior (2012)
Fogaça, Manoela V.; Aguiar, Daniele C.; Moreira, Fabrício A.; Guimarães, Francisco Silveira
Source: Neuropharmacology. Unidade: FMRP
Subjects: ANSIEDADE, FÁRMACOS PSICOTRÓPICOS, CANNABIS (COMPONENTES), CÓRTEX PRÉ-FRONTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOGAÇA, Manoela V. et al. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior. Neuropharmacology, v. 63, n. 2, p. 202-210, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2012.03.007. Acesso em: 02 nov. 2024.
APA
Fogaça, M. V., Aguiar, D. C., Moreira, F. A., & Guimarães, F. S. (2012). The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior. Neuropharmacology, 63( 2), 202-210. doi:10.1016/j.neuropharm.2012.03.007
NLM
Fogaça MV, Aguiar DC, Moreira FA, Guimarães FS. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior [Internet]. Neuropharmacology. 2012 ; 63( 2): 202-210.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2012.03.007
Vancouver
Fogaça MV, Aguiar DC, Moreira FA, Guimarães FS. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior [Internet]. Neuropharmacology. 2012 ; 63( 2): 202-210.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2012.03.007
Artigo de periodico
Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray (2012)
Lisboa, S. F.; Guimarães, Francisco Silveira
Source: Neuropharmacology. Unidade: FMRP
Subjects: CANNABIS (COMPONENTES), SUBSTÂNCIA CINZENTA PERIAQUEDUTAL, COMPORTAMENTO DEFENSIVO ANIMAL, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LISBOA, S. F. e GUIMARÃES, Francisco Silveira. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray. Neuropharmacology, v. 63, n. 8, p. 2455-2462, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2012.02.008. Acesso em: 02 nov. 2024.
APA
Lisboa, S. F., & Guimarães, F. S. (2012). Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray. Neuropharmacology, 63( 8), 2455-2462. doi:10.1016/j.neuropharm.2012.02.008
NLM
Lisboa SF, Guimarães FS. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray [Internet]. Neuropharmacology. 2012 ; 63( 8): 2455-2462.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2012.02.008
Vancouver
Lisboa SF, Guimarães FS. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray [Internet]. Neuropharmacology. 2012 ; 63( 8): 2455-2462.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2012.02.008
Artigo de periodico
Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray (2007)
Moreira, Fabrício Araújo; Aguiar, Daniele Cristina; Guimarães, Francisco Silveira
Source: Neuropharmacology. Unidade: FMRP
Subjects: CANNABIS, ANSIOLÍTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fabrício Araújo e AGUIAR, Daniele Cristina e GUIMARÃES, Francisco Silveira. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology, v. 52, n. 3, p. 958-965, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2006.10.013. Acesso em: 02 nov. 2024.
APA
Moreira, F. A., Aguiar, D. C., & Guimarães, F. S. (2007). Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology, 52( 3), 958-965. doi:10.1016/j.neuropharm.2006.10.013
NLM
Moreira FA, Aguiar DC, Guimarães FS. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray [Internet]. Neuropharmacology. 2007 ; 52( 3): 958-965.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2006.10.013
Vancouver
Moreira FA, Aguiar DC, Guimarães FS. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray [Internet]. Neuropharmacology. 2007 ; 52( 3): 958-965.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.neuropharm.2006.10.013

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Non normalized affiliation